AG
SCMP

Aperio Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Aperio Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,095
Closed -$235K – 2303
2017
Q4 		$235K Buy
13,095
+1,507
+13% +$18.6K ﹤0.01% 2075
2017
Q3 		$137K Buy
+11,588
New +$130K ﹤0.01% 2162
2017
Q2 		– Sell
-10,793
Closed -$119K – 2236
2017
Q1 		$119K Buy
+10,793
New +$125K ﹤0.01% 2097

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Aperio Group's SCMP Position: Q1 2018 in Review

Aperio Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 13,095 shares — an estimated $235K sold.

Aperio Group first reported a position in SCMP in Q1 2017 and held it in 3 quarters. The position peaked at $235K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Aperio Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Aperio Group sold 13,095 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $235K.
  • Aperio Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 3 quarters.
  • Aperio Group's Sucampo Pharmaceuticals, Inc. position peaked at $235K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Aperio Group's 13F filing for Q1 2018, filed 8 May 2018.